| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC2728 |
| Trial ID | NCT04952584 |
| Disease | Hodgkin's Lymphoma | Nasal Type Extranodal NK/T-Cell Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD30.CAR-EBVST |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas |
| Year | 2021 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-49736 TESTA |
| Cohort 1 | |||||||||||
|
|||||||||||